We are live on ! Find out more
SHA

Smith Hayes Advisers Portfolio holdings

AUM $491M
1-Year Est. Return 0.17%
This Fund
S&P 500
This Quarter Est. Return
+2%
1 Year Est. Return
-0.17%
3 Year Est. Return
+35.23%
5 Year Est. Return
10 Year Est. Return
AUM
$491M
AUM Growth
+$16.8M
Cap. Flow
+$9.34M
Cap. Flow %
1.9%
Top 10 Hldgs %
21.8%
Holding
328
New
21
Increased
154
Reduced
98
Closed
21

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$2.06M
2
MET icon
MetLife
MET
+$1.74M
3
FITB
Fifth Third Bancorp
FITB
+$1.53M
4
T icon
AT&T
T
+$1.3M
5
V icon
Visa
V
+$1.13M

Sector Composition

Rank Sector Weight
1 Financials 20.33%
2 Industrials 13.14%
3 Technology 10.23%
4 Consumer Staples 9.4%
5 Healthcare 9.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEVA icon
176
Teva Pharmaceuticals
TEVA
$36.1B
$654K 0.13%
12,217
-699
-5% -$41K
VGT icon
177
Vanguard Information Technology ETF
VGT
$139B
$650K 0.13%
47,480
+400
+0.8% +$5.1K
PEZ icon
178
Invesco Dorsey Wright Consumer Cyclicals Momentum ETF
PEZ
$22.2M
$646K 0.13%
14,741
-750
-5% -$30.9K
LOW icon
179
Lowe's Companies
LOW
$115B
$639K 0.13%
8,431
-957
-10% -$67.5K
XLK icon
180
State Street Technology Select Sector SPDR ETF
XLK
$114B
$635K 0.13%
28,610
+324
+1% +$6.7K
EMN icon
181
Eastman Chemical
EMN
$7.78B
$634K 0.13%
8,775
-12,100
-58% -$793K
SO icon
182
Southern Company
SO
$106B
$627K 0.13%
12,115
+1,035
+9% +$50.4K
PM icon
183
Philip Morris
PM
$300B
$621K 0.13%
6,326
+366
+6% +$33.6K
PTF icon
184
Invesco Dorsey Wright Technology Momentum ETF
PTF
$621M
$586K 0.12%
47,262
-2,406
-5% -$28.3K
OKS
185
DELISTED
Oneok Partners LP
OKS
$584K 0.12%
18,588
+22
+0.1% +$620
GSK icon
186
GSK
GSK
$100B
$579K 0.12%
11,414
-75
-0.7% -$3.73K
GILD icon
187
Gilead Sciences
GILD
$165B
$577K 0.12%
6,282
-6,102
-49% -$550K
IDU icon
188
iShares US Utilities ETF
IDU
$1.38B
$569K 0.12%
9,200
+200
+2% +$11.5K
DD icon
189
DuPont de Nemours
DD
$18.3B
$555K 0.11%
4,313
+369
+9% +$44.2K
LRCX icon
190
Lam Research
LRCX
$384B
$545K 0.11%
66,000
EW icon
191
Edwards Lifesciences
EW
$48.9B
$528K 0.11%
17,955
-27,753
-61% -$766K
TRN icon
192
Trinity Industries
TRN
$2.9B
$520K 0.11%
39,432
+6,564
+20% +$92.2K
EXPE icon
193
Expedia Group
EXPE
$31.8B
$519K 0.11%
4,812
+1,101
+30% +$117K
BKNG icon
194
Booking.com
BKNG
$139B
$516K 0.11%
10,000
-1,375
-12% -$65.8K
RACE icon
195
Ferrari
RACE
$65.3B
$516K 0.11%
+12,390
New +$500K
MAS icon
196
Masco
MAS
$15.6B
$497K 0.1%
15,800
+4,000
+34% +$110K
IXJ icon
197
iShares Global Healthcare ETF
IXJ
$4.03B
$492K 0.1%
10,220
+400
+4% +$19.1K
F icon
198
Ford
F
$55.7B
$491K 0.1%
36,350
+900
+3% +$11.3K
UNH icon
199
UnitedHealth
UNH
$383B
$488K 0.1%
3,784
+97
+3% +$11.5K
KMI icon
200
Kinder Morgan
KMI
$72.5B
$481K 0.1%
26,933
+2,300
+9% +$37.6K

Similar funds

Smith Hayes Advisers's Q1 2016 Portfolio in Review

As of Q1 2016, Smith Hayes Advisers held 328 positions worth $491M, up 3.5% from $475M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Smith Hayes Advisers's Q1 2016 filing shows 21 new, 154 increased, 98 reduced and 21 closed positions. Its largest new stake was Capital One: 16,932 shares worth $1.17M. The largest sale was Invesco S&P 500 Equal Weight ETF, an estimated $2.13M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Industrials and Technology.

  • Smith Hayes Advisers's largest Q1 2016 buy was Capital One: 16,932 shares worth $1.17M.
  • Smith Hayes Advisers added most to Johnson & Johnson in Q1 2016, an estimated $2.06M increase.
  • Smith Hayes Advisers's biggest Q1 2016 reduction was Invesco QQQ Trust, cutting an estimated $1.67M.
  • Smith Hayes Advisers fully exited Invesco S&P 500 Equal Weight ETF in Q1 2016, selling an estimated $2.13M.
  • Smith Hayes Advisers's ten largest holdings make up 22% of its $491M portfolio in Q1 2016.
  • Smith Hayes Advisers opened 21 new positions and closed 21 in Q1 2016.
  • Smith Hayes Advisers's portfolio value rose 3.5% quarter-over-quarter to $491M.

Based on Smith Hayes Advisers's 13F filing for Q1 2016, filed 16 May 2016.